TGFB1 and renal fibrosis: This activates the ROS-NLRP3 inflammasome axis, promotes IL-1β release, and synergizes with TGF-β/Smad signaling to drive EMT and extracellular matrix deposition, accelerating renal fibrosis (126–130).